Objective-To estimate the size of the association between serum concentration of low density lipoprotein cholesterol and mortality from ischaemic heart disease.
Introduction
There is conclusive evidence that the association between serum cholesterol concentration and ischaemic heart disease is one of cause and effect. The size of the association is uncertain, however, and needs to be quantified to assess the effects of dietary change or cholesterol lowering drugs on the risk of ischaemic heart disease. Randomised trials do this directly and have shown that the risk is reversible, but their duration may have been too short to show the full effect. Observational studies, on the other hand, show the effect of long standing differences in cholesterol concentration between people, the differences having been present for many years before recruitment. Direct analysis of data from cohort studies, however, underestimates the association between cholesterol concentration and ischaemic heart disease through two mechanisms, the regression dilution bias and an effect we call the surrogate dilution effect. We therefore derived estimates to allow for these two sources of underestimation to obtain an accurate estimate of the long term reduction in risk of ischaemic heart disease for a given change in serum cholesterol concentration.
REGRESSION DILUTION BIAS
The first source of underestimation, the regression dilution bias, has previously been described. '-5 It affects all regression analyses in which the independent variable (plotted on the horizontal axis) is subject to random variation over time through errors in measurement and fluctuation within a person. The cohort studies of serum cholesterol concentration and ischaemic heart disease have generally measured cholesterol concentration once in each person and ranked the values to divide the cohort into subgroups, usually five equal (quintile) groups. The dose-response relation between the mean cholesterol concentrations of the five groups and the five corresponding death rates for ischaemic heart disease can then be calculated. It is the use of the same measurements both to stratify the cohort into groups and to measure the mean ofeach group that introduces bias.
Because serum cholesterol concentration fluctuates over time single measurements can be higher or lower than the long term average value of an individual person. The groups with the higher cholesterol concentrations will include a disproportionate number of people selected because the single measurement was by chance higher than their long term average value, so the long term mean cholesterol concentration of these groups will be overestimated. Similarly, in the groups with lower concentrations the long term mean cholesterol concentration will be underestimated. The range of concentrations across the groups will be wider if based on single measurements than on long term average values. Both are associated with the same range of death rates for ischaemic heart disease, so a plot of mortality from ischaemic heart disease against serum cholesterol concentration will be shallower when based on single measurements than on long term average values.
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SURROGATE DILUTION EFFECT
In cohort studies a difference of 1 mmol/l in total serum cholesterol concentration might be expected to be equivalent to a difference in low density lipoprotein cholesterol of 0-67 mmol/l (since the latter is about two thirds of total). In intervention studies (trials), however, a reduction in total cholesterol concentration of 1 mmol/l corresponds to a reduction in low density lipoprotein cholesterol of 1 mmol/l because it is this component that is specifically altered by diet6 and by most drugs. It follows that a given difference in total serum cholesterol concentration will correspond to a smaller difference in mortality from ischaemic heart disease in the cohort studies than in the trials (as the major effect on risk of ischaemic heart disease is related to low density lipoprotein cholesterol). Relative to the expected long term results from the trials the large observational studies underestimate the effect on ischaemic heart disease through measuring and classifying subjects by total cholesterol instead of low density lipoprotein cholesterol concentration. This surrogate dilution effect cannot be allowed for simply by using the 067: 1 ratio because of the added complication that total cholesterol also includes high density lipoprotein cholesterol (about a quarter of total), which is inversely associated with low density lipoprotein cholesterol. The extent of the underestimation will therefore be less than the expected 0-67:1 ratio. the original measurements in the cohort of 21 515 men (the group of 5696 men had the same original values); secondly, the mean total cholesterol concentration; thirdly, the mean low density lipoprotein cholesterol concentration ofeach fifth based on the repeat measurements in the group of 5696 men; and fourthly, the age adjusted death rates for ischaemic heart disease for the five groups. The threefold difference in mortality from ischaemic heart disease across the groups (1 11 to 3*11 deaths per 1000 man years) corresponded to a difference in original total cholesterol concentration of 3 1 (from 4-8 to 7 9) mmol/l but a smaller difference in repeat total cholesterol concentration of 2-2 (5-0 to 7 2) mmol/l; this is the regression dilution bias. The threefold difference in mortality from ischaemic heart disease corresponded to an even smaller difference in low density lipoprotein cholesterol concentration of 2-0 (3 3 to 5 3) mmol/l; this is the surrogate dilution effect.
Regression of the mortality from ischaemic heart disease against the mean cholesterol concentration of each fifth of the distribution by using the original measurements of total cholesterol concentration yielded the estimate that a difference of 0-6 mmol/l in total cholesterol concentration corresponded to a difference in mortality from ischaemic heart disease of 14) for the second. This adjustment procedure had high precision with a 95% confidence interval about the final estimate of a 27% decrease in the risk of ischaemic heart disease of 26-5% to 27-5%. The estimate of 61% for the increase of the slope did not vary with age and applied to men of all ages. The decreasing association between serum cholesterol concentration and risk of ischaemic heart disease with age is shown in table II. Mortality from all causes was also significantly associated with concentration of low density lipoprotein cholesterol; over all ages a difference in concentration of low density lipoprotein cholesterol of 0-6 mmol/l was associated with a difference in mortality of 10% (1% to 17%; table II). There was no suggestion of any increase in mortality from causes other than ischaemic heart disease with low cholesterol concentration (table III) , though as reported before there was an excess of mortality from cancer in the lowest fifth in the first two years of follow up, attributable to preclinical cancer lowering cholesterol concentration.7
Discussion
Allowance for the two sources of underestimation increased the regression coefficient, b, by 61% (41% for the regression dilution bias and 14% for the surrogate dilution effect, 1 41 x 1 14= 1 61). The estimate of the difference in mortality from ischaemic heart disease for a difference in cholesterol concentration of 0-6 mmol/l increased from 17% to a final estimate of 27% for the association with long term average values of low density lipoprotein cholesterol. The adjustment procedure was precise, with a 95% confidence interval of 26-5% to 27-5%.
The correction factor for regression dilution bias of all subjects (avoiding the need for the correction), but these studies have recorded relatively few deaths from ischaemic heart disease and lack published data on the appropriate correction for the regression dilution bias for low density lipoprotein cholesterol concentration. Our indirect estimate of the relation between low density lipoprotein cholesterol concentration and ischaemic heart disease has been validated by measurements of apolipoprotein B (the protein component of low density lipoprotein) in men in the BUPA study, which yielded age specific estimates for the association with mortality from ischaemic heart disease (corrected for regression dilution bias) that were close to our present estimates for low density lipoprotein cholesterol concentration.8
In the introduction we indicated that the surrogate dilution effect would be less than expected because the concentrations of high and low density lipoprotein cholesterol were inversely associated. In view of this it is perhaps surprising that high density lipoprotein cholesterol is independent of total cholesterol concentration'0 (our data showed that a 1I00 mmol/l-difference in the concentration of total serum cholesterol was associated with a 0-01 mmol/l (95% confidence interval 0 00 to 002) difference in high density lipoprotein cholesterol). This independence arises because the tendency for the concentrations of high density lipoprotein cholesterol and total cholesterol to be positively associated (because total cholesterol concentration will Public health implications * The association between serum cholesterol concentration and death from ischaemic heart disease is stronger than directly inferred from prospective (cohort) epidemiological studies because of two sources of underestimation that affect these studies * Correction for the underestimation makes the association about half as strong again: a 30% reduction in ischaemic heart disease at age 60, instead of 20%, for a 10% reduction in serum cholesterol concentration * The effect of underestimation was quantified in this study and used to correct the results from other prospective studies * No excess mortality from any cause was apparent in men with low cholesterol concentrations be classified as higher with raised concentration ofhigh density lipoprotein cholesterol) is exactly offset by the modest inverse association between high and low density lipoprotein cholesterol. In practice therefore high density lipoprotein cholesterol does not contribute to the surrogate dilution effect. This effect is entirely due to very low density lipoprotein cholesterol, which is positively associated with total cholesterol but unrelated to the risk of ischaemic heart disease.2" The size of the surrogate dilution effect is small because very low density lipoprotein cholesterol accounts for only about 10% oftotal cholesterol.
We have shown therefore that the results of cohort studies that use single measurements oftotal cholesterol concentrations can be adjusted to produce unbiased estimates of the underlying true relation of low density lipoprotein cholesterol concentration with ischaemic heart disease. A dietary change that lowers total cholesterol concentration by 0-6 mmotl/ lowers low density lipoprotein cholesterol concentration by a similar absolute amount,7 and in middle aged men the corresponding decrease in the risk of ischaemic heart disease is 25-30%.
